Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review
CB Terwee, PJM Elders, MT Blom, JW Beulens… - Diabetologia, 2023 - Springer
Patient-reported outcomes (PROs) are valuable for shared decision making and research.
Patient-reported outcome measures (PROMs) are questionnaires used to measure PROs …
Patient-reported outcome measures (PROMs) are questionnaires used to measure PROs …
Systematic review of the effect of a one-day versus seven-day recall duration on patient reported outcome measures (PROMs)
T Peasgood, JM Caruana, C Mukuria - The Patient-Patient-Centered …, 2023 - Springer
Background There is ongoing uncertainty around the most suitable recall period for patient-
reported outcome measures (PROMs). Method This systematic review integrates …
reported outcome measures (PROMs). Method This systematic review integrates …
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial …
PC Taylor, ME Weinblatt, IB McInnes… - Annals of the …, 2023 - ard.bmj.com
Objectives To investigate the efficacy and safety of otilimab, an anti-granulocyte-
macrophage colony-stimulating factor antibody, in patients with active rheumatoid arthritis …
macrophage colony-stimulating factor antibody, in patients with active rheumatoid arthritis …
Patient-centric assessment of rheumatoid arthritis using a smartwatch and bespoke mobile app in a clinical setting
V Hamy, C Llop, CW Yee, L Garcia-Gancedo… - Scientific Reports, 2023 - nature.com
Rheumatoid arthritis (RA) is a fluctuating progressive disease requiring frequent symptom
assessment for appropriate management. Continuous tracking using digital technologies …
assessment for appropriate management. Continuous tracking using digital technologies …
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two …
RM Fleischmann, D van der Heijde, V Strand… - Annals of the …, 2023 - ard.bmj.com
Objectives To investigate the efficacy and safety of otilimab, an antigranulocyte-macrophage
colony-stimulating factor antibody, in patients with active rheumatoid arthritis. Methods Two …
colony-stimulating factor antibody, in patients with active rheumatoid arthritis. Methods Two …
Validation of the PROMIS sleep disturbance item bank computer adaptive test (CAT) in patients on renal replacement therapy
J Hussain, G Chawla, H Rafiqzad, S Huang, SJ Bartlett… - Sleep Medicine, 2022 - Elsevier
Objective To examine the validity and reliability of the PROMIS Sleep Disturbance Item Bank
Computer Adaptive Test (PROMIS-SD CAT) in patients on renal replacement therapy, using …
Computer Adaptive Test (PROMIS-SD CAT) in patients on renal replacement therapy, using …
Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis
MMH Teuwen, TPMV Vlieland, SFE van Weely… - Rheumatology …, 2024 - Springer
To describe the quality of reporting and the nature of reported harms in clinical studies on
the effectiveness of supervised exercises in patients with rheumatoid arthritis (RA) or axial …
the effectiveness of supervised exercises in patients with rheumatoid arthritis (RA) or axial …
Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS® Short Forms: a study in patients with axial …
A Findley, JM Middlehurst, CA Howse… - Journal of Patient …, 2023 - Springer
Background Sleep disturbance, pain, and fatigue are key symptoms/impacts of axial
spondyloarthritis (axSpA). Three customized Patient-Reported Outcomes Measurement …
spondyloarthritis (axSpA). Three customized Patient-Reported Outcomes Measurement …
The use of PROMIS measures in clinical studies in patients with inflammatory arthritis: A systematic review
MMH Teuwen, IRE Knaapen, TPM Vliet Vlieland… - Quality of Life …, 2023 - Springer
Purpose Although the use of Patient-Reported Outcomes Measurement Information System
(PROMIS) measures is widely advocated, little is known on their use in patients with …
(PROMIS) measures is widely advocated, little is known on their use in patients with …
Assessing sleep and pain among adults with myalgic encephalomyelitis/chronic fatigue syndrome: psychometric evaluation of the PROMIS® sleep and pain short …
M Yang, S Keller, JMS Lin - Quality of Life Research, 2022 - Springer
Purpose To evaluate the psychometric properties of the patient-reported outcome
measurement information system®(PROMIS) short forms for assessing sleep disturbance …
measurement information system®(PROMIS) short forms for assessing sleep disturbance …